Experts warn against decoupling safety and effectiveness from FDA approval
Regulatory NewsJeff Craven
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesPharmaceuticalsProduct LifecycleSubmission and registrationUnited StatesUS Food and Drug Administration (FDA)